[EN] INHIBITORS OF DDR1 AND DDR2 FOR THE TREATMENT OF ARTHRITIS<br/>[FR] INHIBITEURS DE DDR1 ET DDR2 POUR LE TRAITEMENT DE L'ARTHRITE
申请人:[en]PRESIDENT AND FELLOWS OF HARVARD COLLEGE
公开号:WO2023196714A2
公开(公告)日:2023-10-12
Provided herein are compounds, such as compounds of Formulae (I) and (II), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein are DDR1, DDR2, or p38 MAPK (e.g., p38-alpha) inhibitors and are therefore useful for the treatment and/or prevention of various diseases and conditions (e.g., inflammatory diseases, joint diseases, proliferative diseases, fibrosis, or pain).